CLDN18 and familial pancreatic carcinoma: The results generated from these sessions are summarized in this manuscript and are proposed as consensus recommendations for evaluating and scoring CLDN18 immunohistochemical staining in pancreatic cancer specimens and we describe our experience and our recommendations below.